UroGen Pharma Ltd. (URGN) › Net IncomeUroGen Pharma Ltd. (URGN) — Net IncomeAnnual figures by fiscal year, from SEC filings.2015: -$12.69M2016: -$1.94M2017: -$20.00M2018: -$75.66M2019: -$105.15M2020: -$128.48M2021: -$110.82M2022: -$109.78M2023: -$102.24M2024: -$126.87M2025: -$153.49M-$153.49M2015Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$153.49M-21.0%2024-$126.87M-24.1%2023-$102.24M+6.9%2022-$109.78M+0.9%2021-$110.82M+13.7%2020-$128.48M-22.2%2019-$105.15M-39.0%2018-$75.66M-278.3%2017-$20.00M-930.4%2016-$1.94M+84.7%2015-$12.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share